Patents by Inventor Deyong YE

Deyong YE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkoxybenzo-five-membered (six-membered) heterocyclic amine compound and pharmaceutical use thereof
    Patent number: 11396504
    Abstract: Alkoxybenzeno five- or six-member heterocyclic amines compounds, their pharmaceutically acceptable salts, and pharmaceutical compositions are used as the active ingredients, and their application in drugs which can prevent and cure diseases caused by abnormal increasing of SM. These diseases caused by abnormal increasing of SM include atherosclerosis, type II diabetes, fatty liver, obesity, metabolic syndromes, enteritis and other inflammatory diseases.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: July 26, 2022
    Assignee: FUDAN UNIVERSITY
    Inventors: Deyong Ye, Mingguang Mo, Jintong Yang, Lu Zhou, Yong Chu, Jinyu Fei, Xiangyu Qi
  • Alkoxybenzo-five-membered (six-membered) heterocyclic amine compound and pharmaceutical use thereof
    Publication number: 20210032230
    Abstract: Alkoxybenzeno five- or six-member heterocyclic amines compounds, their pharmaceutically acceptable salts, and pharmaceutical compositions are used as the active ingredients, and their application in drugs which can prevent and cure diseases caused by abnormal increasing of SM. These diseases caused by abnormal increasing of SM include atherosclerosis, type II diabetes, fatty liver, obesity, metabolic syndromes, enteritis and other inflammatory diseases.
    Type: Application
    Filed: January 21, 2019
    Publication date: February 4, 2021
    Inventors: Deyong YE, Mingguang MO, Jintong YANG, Lu ZHOU, Yong CHU, Jinyu FEI, Xiangyu QI
  • 2-alkyloxy benzene formyl arylamine compound and pharmaceutical use thereof
    Patent number: 10196359
    Abstract: 2-alkoxy benzene formyl arylamine compounds and their pharmaceutical salts are disclosed. The compounds can act as sphingomyelin synthase (SMS) inhibitors to treat diseases caused by abnormal increasing of sphingomyelin (SM). The pharmaceutically acceptable salts and pharmaceutical compositions of the compounds are used as active ingredients in drugs which can prevent and cure diseases caused by SM level abnormal increase. These diseases include atherosclerosis, fatty liver, obesity, type diabetes, and other metabolic syndromes.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: February 5, 2019
    Assignee: FUDAN UNIVERSITY
    Inventors: Deyong Ye, Yali Li, Lu Zhou, Penghui Wang, Yong Chu, Haojun Gong, Qi Huang, Yan Chen, Zhikuan Zhang
  • 2-Alkyloxy benzene formyl arylamine compound and pharmaceutical use thereof
    Publication number: 20170253564
    Abstract: 2-alkoxy benzene formyl arylamine compounds and their pharmaceutical salts are disclosed. The compounds can act as sphingomyelin synthase (SMS) inhibitors to treat diseases caused by abnormal increasing of sphingomyelin (SM). The pharmaceutically acceptable salts and pharmaceutical compositions of the compounds are used as active ingredients in drugs which can prevent and cure diseases caused by SM level abnormal increase. These diseases include atherosclerosis, fatty liver, obesity, type diabetes, and other metabolic syndromes.
    Type: Application
    Filed: July 24, 2015
    Publication date: September 7, 2017
    Inventors: Deyong YE, Yali LI, Lu ZHOU, Penghui WANG, Yong CHU, Haojun GONG, Qi HUANG, Yan CHEN, Zhikuan ZHANG